Salute e Benessere
Topical Drug Delivery Market US$409.0 Billion Forecast by 2030 with 8.8% CAGR | MarketsandMarkets™
the topical drug delivery market is segmented into semi-solid formulations, liquid formulations, solid formulations, transdermal products, and other products. Other products include stick, aerosol (spray), and foam. The large share of the semi-solid formulations segment is attributed to its convenience and ease of application, limited side effects that improve patient adherence, and the ability to topically deliver a wide variety of drug molecules compared to other formulations.
the market is segmented into dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, and nasal drug delivery. In 2024, the dermal drug delivery segment accounted for the largest share of the market. The large share of this segment is attributed to the several key advantages offered, such as the ease of use and increased patient compliance for long-term treatment in conditions for chronic pain or skin disorders. Dermal drugs also have fewer regulatory requirements than ophthalmic products, which leads to increasingly accessible product launches and broad adoption.
the market is segmented into home care settings, ambulatory surgery centers, hospitals & clinics, burn care centres, and other end users. The home care settings segment accounted for the largest share of the market in 2024. Topical drug delivery systems are increasingly gaining prominence, not just as an alternative route of drug delivery but also as point-of-care devices in home care settings. The market's growth is primarily attributed to improved patient accessibility owing to high awareness and comfort.
, in 2024, North America accounted for the largest share of the topical drug delivery market, followed by Europe , the Asia Pacific , Latin America , and the Middle East & Africa . Market growth in this region is characterized by the availability of favorable reimbursement options, increasing awareness about novel pharmaceutical drug delivery technologies, the implementation of favorable government initiatives, growing affordability and per capita healthcare expenditure, and the presence of several global pharmaceutical giants.
The prominent players in the topical drug delivery market are Johnson & Johnson Services, Inc. (US), Galderma ( Switzerland ), Bayer AG ( Germany ), Novartis AG ( Switzerland ), AbbVie Inc. (US), GSK Plc. (UK), Bausch Health Companies Inc. ( Canada ), Glenmark Pharmaceuticals Limited ( India ), Hisamitsu Pharmaceuticals Inc. ( Japan ), Cipla ( India ), Boehringer Ingelheim International GmbH ( Germany ), Pfizer Inc. (US), Teva Pharmaceuticals Industries Ltd. ( Israel ), Viatris Inc. (US), Organon group of companies (US), , Solventum (US), Crescita Therpeautics Inc. ( Canada ), Luye Pharma Group ( China ), Lead Chemical Co., Ltd. ( Japan ), Purdue Pharma L.P. (US), Lavipharm ( Greece ), CMP Pharma, Inc. ( Germany ), Encore Dermatology, Inc. (US), Rusan Pharma Ltd. ( India ) and AdhexPharma ( France ).
The company primarily focuses on human health and well-being. J&J operates through two business segments: Innovative Medicine and MedTech. Topical drug delivery products fall under the Innovative Medicine segment, which is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, inflammatory bowel disease, and psoriasis), Infectious Diseases (e.g., HIV/AIDS), Neuroscience (e.g., mood disorders, neurodegenerative disorders, and schizophrenia), Oncology (e.g., prostate cancer and hematologic malignancies), Cardiovascular and Metabolism (e.g., thrombosis and diabetes), and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). The company has a strong presence across North America , Europe , the Asia Pacific , and Africa .
Galderma offers premium brands and services across injectable aesthetics, dermatological skincare, and therapeutic dermatology. The company provides topical products under all three segments. Injectable Aesthetics consists of hyaluronic acid (HA) fillers and botulinum neuromodulators. Dermatological skincare consists of consumer care brands such as Cetaphil, with its wide range of skincare products for all ages; Benzac and Differin OTC for mild-to-moderate acne; and Loceryl, used to treat fungal nail infections. The company operates globally with research and development centers and manufacturing sites throughout the Asia Pacific , Europe , the Middle East , Africa , and North & Latin America .
For more information,
Get access to the latest updates on and
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, , and . With a , we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/topical-drug-delivery-market-us409-0-billion-forecast-by-2030-with-8-8-cagr--marketsandmarkets-302521710.html